abstract |
Anthranilic acid amides with a heteroarylsulfonyl side chain of formula (I) are disclosed, wherein R1 to R7 are as defined in the specification. These compounds act upon the Kv1.5-potassium channel and inhibit a potassium flow in the atrium of the human heart, designated as an ultra-rapidly activating delayed rectifier. As a result, they are particularly suitable for use as antiarrhythmic active substances, especially in the treatment and prophylaxis of atrial arrhythmia, e.g. atrial fibrillation (AF) or atrial flutter. |